| Title | Cost-effectiveness of enfuvirtide in treatment-experienced patients with advanced HIV disease. |
| Publication Type | Journal Article |
| Year of Publication | 2005 |
| Authors | Sax, Paul E., Elena Losina, Milton C. Weinstein, David A. Paltiel, Sue J. Goldie, Tammy M. Muccio, April D. Kimmel, Hong Zhang, Kenneth A. Freedberg, and Rochelle P. Walensky |
| Journal | Journal of acquired immune deficiency syndromes (1999) |
| Volume | 39 |
| Issue | 1 |
| Pagination | 69-77 |
| Date Published | 2005 May 1 |
| ISSN | 1525-4135 |
| Keywords | Adult, CD4 Lymphocyte Count, Cost-Benefit Analysis, Drug Therapy, Combination, Female, HIV Envelope Protein gp41, HIV Fusion Inhibitors, HIV Infections, Humans, Male, Middle Aged, Peptide Fragments, Quality of Life, Reproducibility of Results, Sensitivity and Specificity, Survival Analysis, United States |
| Abstract | Enfuvirtide (ENF) has been shown to improve short-term virologic responses when given to highly treatment-experienced patients with advanced HIV disease. Because of the high cost of ENF compared with other antiretroviral agents, our objectives were to determine the potential long-term clinical impact and cost-effectiveness of ENF in these patients. |
| DOI | 10.1111/j.1524-4733.2010.00763.x |
| Alternate Journal | J. Acquir. Immune Defic. Syndr. |
